LNAI — LUNAI BIOWORKS INC. (Healthcare >> Biotechnology)
LNAI FAQ
What is LNAI's P/E ratio?
LUNAI BIOWORKS INC. (LNAI) currently trades at a P/E ratio of 4.02.
What is LNAI's ROE?
LUNAI BIOWORKS INC. reports a Return on Equity (ROE) of 1,342.81%.
What is LNAI's dividend yield?
LUNAI BIOWORKS INC. offers a dividend yield of 0.00%.
What is LNAI's Deepscope Quality Score?
Deepscope rates LNAI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy LNAI?
Deepscope's AI Timing Score for LNAI is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does LNAI belong to?
LUNAI BIOWORKS INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.41
Price
-0.09
(-3.60%)
Day Change
|
|
|---|
LNAI Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.41 |
| PBV / Sector |
-1.19 / 4.91
|
| Earning Per Share | -27.28 |
| PE / Sector |
4.02 / 18.34
GREAT
|
| PEG or PE/Growth / Sector |
-0.61 / 0.61
|
| Average 1M Daily Value |
0.32 M
GREAT
|
| Average 1W Daily Value |
0.08 M
GREAT
|
| Yếu tố Kỹ thuật |
|
57% |
| Sức khỏe tài chính |
|
37% |
| Khả năng kiếm lợi nhuận |
|
43% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-13 11:13:41 |
| Symbol | LNAI |
| Name | LUNAI BIOWORKS INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 4.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11.33 / 9,034.83 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2080 Century Park East, Los Angeles, CA, United States, 90067
Phone: 305 918 1980
Website: https://www.lunaibioworks.com
Sector: Healthcare >> Biotechnology
Description: Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google